Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
25
OFIX Quote, Financials, Valuation and Earnings
Last price:
$10.85
Seasonality move
:
-2.8%
Day range:
$10.54 - $10.94
52-week range:
$10.24 - $20.73
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.51x
P/B ratio:
0.91x
Volume:
304K
Avg. volume:
421.7K
1-year change:
-33.71%
Market cap:
$419.2M
Revenue:
$799.5M
EPS (TTM):
-$3.69
Analysts' Opinion
-
Consensus RatingOrthofix Medical has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $22.30, Orthofix Medical has an estimated upside of 108.41% from its current price of $10.70.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $16.00 representing 100% downside risk from its current price of $10.70.
Fair Value
-
According to the consensus of 3 analysts, Orthofix Medical has 108.41% upside to fair value with a price target of $22.30 per share.
OFIX vs. S&P 500
-
Over the past 5 trading days, Orthofix Medical has underperformed the S&P 500 by -5.29% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Orthofix Medical does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Orthofix Medical has grown year-over-year revenues for 9 quarters straight. In the most recent quarter Orthofix Medical reported revenues of $193.6M.
Earnings Growth
-
Orthofix Medical has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Orthofix Medical reported earnings per share of -$1.35.
Enterprise value:
518.2M
EV / Invested capital:
--
Price / LTM sales:
0.51x
EV / EBIT:
--
EV / Revenue:
0.64x
PEG ratio (5yr expected):
-0.32x
EV / Free cash flow:
-107.93x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$540.3M
Return On Assets:
-16.36%
Net Income Margin (TTM):
-17.78%
Return On Equity:
-27.48%
Return On Invested Capital:
-21.86%
Operating Margin:
-25.55%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $529.5M | $760M | $804.5M | $188.6M | $193.6M | |
| Gross Profit | $369.4M | $503.2M | $540.3M | $127.2M | $121.6M | |
| Operating Income | -$75.9M | -$110.2M | -$99M | -$28.2M | -$49.5M | |
| EBITDA | -$33.3M | -$49.1M | -$15.9M | -$14.3M | -$11.9M | |
| Diluted EPS | -$2.47 | -$3.38 | -$3.69 | -$0.95 | -$1.35 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $263.4M | $255.1M | $410M | $399M | $390.3M | |
| Total Assets | $513.9M | $462M | $917.1M | $906.1M | $823.1M | |
| Current Liabilities | $99.1M | $88.2M | $137.6M | $150.6M | $144.1M | |
| Total Liabilities | $159.1M | $126.4M | $253M | $335.7M | $364.9M | |
| Total Equity | $354.8M | $335.6M | $664.2M | $570.3M | $458.3M | |
| Total Debt | -- | -- | $45M | $118.2M | $156.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$37.8M | -$30.3M | $26M | -$18.6M | -$18.4M | |
| Cash From Investing | -$1.8M | -$61.1M | -$23.4M | -$10.9M | -$6.7M | |
| Cash From Financing | $18.1M | $70.8M | $28.6M | $21.5M | -$651K | |
| Free Cash Flow | -$67.2M | -$91.4M | -$4.8M | -$29.4M | -$25.1M | |
OFIX
Sector
Market Cap
$419.2M
$34.4M
Price % of 52-Week High
51.62%
48.88%
Dividend Yield
0%
0%
Shareholder Yield
-2.95%
-1.01%
1-Year Price Total Return
-33.71%
-37.36%
Beta (5-Year)
0.796
0.614
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$11.02
200-day SMA
Sell
Level
$15.49
Bollinger Bands (100)
Sell
Level
11 - 15.94
Chaikin Money Flow
Buy
Level
137.2K
20-day SMA
Sell
Level
$10.93
Relative Strength Index (RSI14)
Sell
Level
41.05
ADX Line
Sell
Level
18.3
Williams %R
Buy
Level
-84.9057
50-day SMA
Sell
Level
$11.33
MACD (12, 26)
Buy
Level
2.98
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Sell
Level
-564.1K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.5029)
Buy
CA Score
(Annual)
Level (-0.101)
Buy
Beneish M-Score
(Annual)
Level (-3.3834)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (0.5917)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
Stock Forecast FAQ
In the current month, OFIX has received 2 Buy ratings 1 Hold ratings, and 0 Sell ratings. The OFIX average analyst price target in the past 3 months is $22.30.
-
Where Will Orthofix Medical Stock Be In 1 Year?
According to analysts, the consensus estimate is that Orthofix Medical share price will rise to $22.30 per share over the next 12 months.
-
What Do Analysts Say About Orthofix Medical?
Analysts are divided on their view about Orthofix Medical share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Orthofix Medical is a Sell and believe this share price will drop from its current level to $16.00.
-
What Is Orthofix Medical's Price Target?
The price target for Orthofix Medical over the next 1-year time period is forecast to be $22.30 according to 3 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is OFIX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Orthofix Medical is a Buy. 2 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of OFIX?
You can purchase shares of Orthofix Medical via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Orthofix Medical shares.
-
What Is The Orthofix Medical Share Price Today?
Orthofix Medical was last trading at $10.85 per share. This represents the most recent stock quote for Orthofix Medical. Yesterday, Orthofix Medical closed at $10.70 per share.
-
How To Buy Orthofix Medical Stock Online?
In order to purchase Orthofix Medical stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
